Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?Ester Fernández-Salas, Helen Ho, Patton Garay, et al.Plos One|November 28, 2012
Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassayEster Fernández-Salas, Joanne Wang, Yanira Molina, et al.Toxins|June 27, 2015
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25Catherine Rhéaume, Brian B Cai, Joanne Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Plasma membrane localization signals in the light chain of botulinum neurotoxinEster Fernández-Salas, Lance E Steward, Helen Ho, et al.Angewandte Chemie (International Ed. in English)|December 29, 2017
Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein-Protein InteractionShilin Xu, Angelo Aguilar, Tianfeng Xu, et al.The Journal of Biological Chemistry|April 11, 2008
Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristicsJiafu Wang, Jianghui Meng, Gary W Lawrence, et al.Plos Pathogens|May 23, 2013
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A)Birgitte P S Jacky, Patton E Garay, Jérôme Dupuy, et al.Molecular and Cellular Biology|May 9, 2002
mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53Ester Fernández-Salas, Kwang S Suh, Vladislav V Speransky, et al.Journal of Medicinal Chemistry|May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer TherapyDillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.Pageof 1